• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PMS777是一种具有抗血小板活化因子活性的新型胆碱酯酶抑制剂,可在体外调节淀粉样前体蛋白的加工过程。

PMS777, a new cholinesterase inhibitor with anti-platelet activated factor activity, regulates amyloid precursor protein processing in vitro.

作者信息

Yang Hong-Qi, Sun Zhi-Kun, Zhao Yan-Xin, Pan Jing, Ba Mao-Wen, Lu Guo-Qiang, Ding Jian-Qing, Chen Hong-Zhuan, Chen Sheng-Di

机构信息

Department of Neurology, Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, People's Republic of China.

出版信息

Neurochem Res. 2009 Mar;34(3):528-35. doi: 10.1007/s11064-008-9816-4. Epub 2008 Aug 29.

DOI:10.1007/s11064-008-9816-4
PMID:18758955
Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder characterized clinically by progressive impairment of memory and cognition. Previous data have shown that beta-amyloid (Abeta) cascade plays a central role in AD pathophysiology and thus drugs regulate amyloid precursor protein (APP) metabolism may have therapeutic potential. Here the effects of PMS777, a new cholinesterase inhibitor with anti-platelet activated factor activity, on APP processing were investigated. Using SH-SY5Y(APP695) cells, it showed that PMS777 treatment caused significant decreased secretion of sAPPalpha into the conditioned media without affecting cellular holoAPP synthesis. When PC12 cells were incubated with PMS777, the same effect was observed. The data also indicated that 10 muM PMS777 incubation decreased the release of Abeta42 into the cell media as compared with vehicle group in SH-SY5Y(APP695) cells. Pretreatment of cells with M-receptor scopolamine antagonized the decreased secretion of sAPPalpha induced by PMS777, but N-receptor alpha-bungarotoxin pretreatment did not have such an effect. These results indicated that PMS777 could modulate APP processing in vitro and that decreasing Abeta generation might demonstrate its therapeutic potential in AD.

摘要

阿尔茨海默病(AD)是一种神经退行性疾病,临床上以记忆力和认知能力的进行性损害为特征。先前的数据表明,β-淀粉样蛋白(Aβ)级联反应在AD的病理生理过程中起核心作用,因此调节淀粉样前体蛋白(APP)代谢的药物可能具有治疗潜力。在此,研究了一种具有抗血小板活化因子活性的新型胆碱酯酶抑制剂PMS777对APP加工的影响。使用SH-SY5Y(APP695)细胞,结果显示PMS777处理导致条件培养基中sAPPα的分泌显著减少,而不影响细胞内全长APP的合成。当PC12细胞与PMS777孵育时,也观察到了相同的效果。数据还表明,在SH-SY5Y(APP695)细胞中,与溶剂对照组相比,10μM PMS777孵育可减少Aβ42释放到细胞培养基中。用M受体东莨菪碱预处理细胞可拮抗PMS777诱导的sAPPα分泌减少,但N受体α-银环蛇毒素预处理则没有这种作用。这些结果表明,PMS777可在体外调节APP加工,减少Aβ生成可能显示其在AD中的治疗潜力。

相似文献

1
PMS777, a new cholinesterase inhibitor with anti-platelet activated factor activity, regulates amyloid precursor protein processing in vitro.PMS777是一种具有抗血小板活化因子活性的新型胆碱酯酶抑制剂,可在体外调节淀粉样前体蛋白的加工过程。
Neurochem Res. 2009 Mar;34(3):528-35. doi: 10.1007/s11064-008-9816-4. Epub 2008 Aug 29.
2
Protection of PMS777, a new AChE inhibitor with PAF antagonism, against amyloid-beta-induced neuronal apoptosis and neuroinflammation.新型具有血小板活化因子(PAF)拮抗作用的乙酰胆碱酯酶(AChE)抑制剂PMS777对β-淀粉样蛋白诱导的神经元凋亡和神经炎症的保护作用。
Cell Mol Neurobiol. 2009 Jun;29(4):589-95. doi: 10.1007/s10571-009-9351-0. Epub 2009 Feb 5.
3
Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.新型具有PAF拮抗活性的乙酰胆碱酯酶抑制剂PMS777的药理学特性
Int J Neuropsychopharmacol. 2007 Feb;10(1):21-9. doi: 10.1017/S1461145705006425. Epub 2006 Jan 23.
4
PMS777, a bis-interacting ligand for PAF receptor antagonism and AChE inhibition, attenuates PAF-induced neurocytotoxicity in SH-SY5Y cells.PMS777是一种用于拮抗PAF受体和抑制乙酰胆碱酯酶的双相互作用配体,可减轻PAF诱导的SH-SY5Y细胞神经细胞毒性。
Cell Mol Neurobiol. 2008 Jan;28(1):125-36. doi: 10.1007/s10571-007-9190-9. Epub 2007 Aug 22.
5
Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.石杉碱甲通过蛋白激酶C和丝裂原活化蛋白激酶途径调节过表达野生型人淀粉样前体蛋白695的神经母细胞瘤SK-N-SH细胞中淀粉样前体蛋白的加工过程。
Neuroscience. 2007 Dec 5;150(2):386-95. doi: 10.1016/j.neuroscience.2007.09.022. Epub 2007 Sep 14.
6
Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.新型乙酰胆碱酯酶抑制剂PMS777与加兰他敏对人神经母细胞瘤SK-N-SH细胞诱导的氧化损伤的差异作用。
Neurosci Lett. 2005 Dec 2;389(2):61-5. doi: 10.1016/j.neulet.2005.07.026.
7
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.乙酰胆碱酯酶抑制剂通过促进其在神经母细胞瘤细胞系中的运输来增加ADAM10活性。
J Neurochem. 2004 Sep;90(6):1489-99. doi: 10.1111/j.1471-4159.2004.02680.x.
8
A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrine.
Int Immunopharmacol. 2007 Dec 15;7(13):1685-94. doi: 10.1016/j.intimp.2007.08.023. Epub 2007 Sep 19.
9
Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein.东莨菪碱对转基因阿尔茨海默病样Tg2576小鼠毒蕈碱型乙酰胆碱受体的抑制作用有利于淀粉样前体蛋白的淀粉样生成加工途径。
Int J Dev Neurosci. 2006 Apr-May;24(2-3):149-56. doi: 10.1016/j.ijdevneu.2005.11.010. Epub 2006 Jan 19.
10
New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity.新型蛋白激酶C激活剂通过提高α-分泌酶活性在体外调节淀粉样前体蛋白的加工过程。
Eur J Neurosci. 2007 Jul;26(2):381-91. doi: 10.1111/j.1460-9568.2007.05648.x.

引用本文的文献

1
Aβ1-42-containing platelet-derived extracellular vesicle is associated with cognitive decline in Parkinson's disease.含β淀粉样蛋白1-42的血小板衍生细胞外囊泡与帕金森病的认知衰退相关。
Front Aging Neurosci. 2023 Apr 14;15:1170663. doi: 10.3389/fnagi.2023.1170663. eCollection 2023.
2
Neuroprotective effects of donepezil against Aβ-induced neurotoxicity.多奈哌齐对 Aβ 诱导的神经毒性的神经保护作用。
Eur J Med Res. 2022 Oct 28;27(1):219. doi: 10.1186/s40001-022-00862-1.
3
AChE Inhibition-based Multi-target-directed Ligands, a Novel Pharmacological Approach for the Symptomatic and Disease-modifying Therapy of Alzheimer's Disease.

本文引用的文献

1
Pharmacological profile of PMS777, a new AChE inhibitor with PAF antagonistic activity.新型具有PAF拮抗活性的乙酰胆碱酯酶抑制剂PMS777的药理学特性
Int J Neuropsychopharmacol. 2007 Feb;10(1):21-9. doi: 10.1017/S1461145705006425. Epub 2006 Jan 23.
2
Rationalizing therapeutic approaches in Alzheimer's disease.优化阿尔茨海默病的治疗方法。
CNS Spectr. 2005 Nov;10(11 Suppl 18):17-21. doi: 10.1017/s109285290001419x.
3
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
基于乙酰胆碱酯酶抑制的多靶点导向配体,一种用于阿尔茨海默病症状性和疾病修饰治疗的新型药理学方法。
Curr Neuropharmacol. 2016;14(4):364-75. doi: 10.2174/1570159x14666160119094820.
4
Meserine, a novel carbamate AChE inhibitor, ameliorates scopolamine-induced dementia and alleviates amyloidogenesis of APP/PS1 transgenic mice.美塞林是一种新型氨基甲酸酯类乙酰胆碱酯酶抑制剂,可改善东莨菪碱诱导的痴呆,并减轻APP/PS1转基因小鼠的淀粉样蛋白生成。
CNS Neurosci Ther. 2014 Feb;20(2):165-71. doi: 10.1111/cns.12183. Epub 2013 Nov 27.
5
Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau.当前阿尔茨海默病治疗的进展:聚焦于针对 Aβ 和 tau 的考虑因素。
Transl Neurodegener. 2012 Oct 30;1(1):21. doi: 10.1186/2047-9158-1-21.
6
A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease.他克林对原代培养胎鼠皮质神经细胞神经退行性变模型中突触前蛋白和神经元活力的新型作用及其在阿尔茨海默病中的意义。
J Neurochem. 2010 Feb;112(4):843-53. doi: 10.1111/j.1471-4159.2009.06490.x. Epub 2009 Nov 11.
淀粉样β蛋白可被细胞血管紧张素转换酶(ACE)降解,而一种ACE抑制剂可使其水平升高。
J Biol Chem. 2005 Nov 11;280(45):37644-50. doi: 10.1074/jbc.M508460200. Epub 2005 Sep 9.
4
Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides.β淀粉样蛋白通过半胱天冬酶级联反应导致神经元细胞凋亡,而β淀粉样蛋白衍生的短肽可以预防这种情况。
Exp Neurol. 2005 Dec;196(2):282-9. doi: 10.1016/j.expneurol.2005.08.001. Epub 2005 Aug 30.
5
Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.新型乙酰胆碱酯酶抑制剂PMS777与加兰他敏对人神经母细胞瘤SK-N-SH细胞诱导的氧化损伤的差异作用。
Neurosci Lett. 2005 Dec 2;389(2):61-5. doi: 10.1016/j.neulet.2005.07.026.
6
Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 up-regulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway.β-淀粉样蛋白诱导的细胞凋亡与通过丝裂原活化蛋白激酶-NF-κB信号通路导致的环氧化酶-2上调有关。
Free Radic Biol Med. 2005 Jun 15;38(12):1604-13. doi: 10.1016/j.freeradbiomed.2005.02.023. Epub 2005 Mar 24.
7
Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.β-淀粉样蛋白降解酶随年龄和区域的变化:对β-淀粉样蛋白诱导疾病的影响。
Neurobiol Aging. 2005 May;26(5):645-54. doi: 10.1016/j.neurobiolaging.2004.06.013.
8
Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.转甲状腺素蛋白的中和作用逆转了分泌型淀粉样前体蛋白(APP)在APPSW小鼠中的神经保护作用,导致tau蛋白磷酸化和海马神经元丢失:对淀粉样蛋白假说的支持。
J Neurosci. 2004 Sep 1;24(35):7707-17. doi: 10.1523/JNEUROSCI.2211-04.2004.
9
Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.乙酰胆碱酯酶抑制剂通过促进其在神经母细胞瘤细胞系中的运输来增加ADAM10活性。
J Neurochem. 2004 Sep;90(6):1489-99. doi: 10.1111/j.1471-4159.2004.02680.x.
10
Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.蛋白激酶C激活剂对阿尔茨海默病转基因小鼠的治疗作用。
Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11141-6. doi: 10.1073/pnas.0403921101. Epub 2004 Jul 19.